{"id":"https://openalex.org/W2891825792","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4150","title":"A phase I/II study of ribociclib plus everolimus in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) refractory to chemotherapy.","display_name":"A phase I/II study of ribociclib plus everolimus in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) refractory to chemotherapy.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2891825792","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4150","mag":"2891825792"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.tps4150","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4150","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4150","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055915497","display_name":"Benjamin Adam Weinberg","orcid":"https://orcid.org/0000-0002-0408-4817","observed_orcids":["https://orcid.org/0000-0002-0408-4817"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Adam Weinberg","raw_affiliation_strings":["Georgetown Lombardi Comprehensive Cancer Center, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown Lombardi Comprehensive Cancer Center, Washington, DC;","institution_ids":["https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101805457","display_name":"Hongkun Wang","orcid":"https://orcid.org/0000-0002-5443-319X","observed_orcids":["https://orcid.org/0000-0002-5443-319X"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongkun Wang","raw_affiliation_strings":["Georgetown University, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University, Washington, DC;","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034535391","display_name":"Agnieszka Katarzyna Witkiewicz","orcid":"https://orcid.org/0000-0003-4538-1145","observed_orcids":["https://orcid.org/0000-0003-4538-1145"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Agnieszka Katarzyna Witkiewicz","raw_affiliation_strings":["University of Arizona, Tucson, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona, Tucson, AZ;","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061373605","display_name":"John Lindsay Marshall","orcid":"https://orcid.org/0000-0002-3449-2344","observed_orcids":["https://orcid.org/0000-0002-3449-2344"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Marshall","raw_affiliation_strings":["Georgetown University Medical Center, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University Medical Center, Washington, DC;","institution_ids":["https://openalex.org/I2799903593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029801038","display_name":"Erik S. Knudsen","orcid":"https://orcid.org/0000-0002-5130-5969","observed_orcids":["https://orcid.org/0000-0002-5130-5969"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik S. Knudsen","raw_affiliation_strings":["University of Arizona, Tucson, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona, Tucson, AZ;","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021453899","display_name":"Michael Jon Pishvaian","orcid":"https://orcid.org/0000-0002-1165-9041","observed_orcids":["https://orcid.org/0000-0002-1165-9041"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Pishvaian","raw_affiliation_strings":["Georgetown University Medical Center, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University Medical Center, Washington, DC;","institution_ids":["https://openalex.org/I2799903593"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"TPS4150","last_page":"TPS4150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9359999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9359999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.05739999935030937,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.968999981880188},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":1.0},{"id":"https://openalex.org/keywords/metastatic-pancreatic-adenocarcinoma","display_name":"metastatic pancreatic adenocarcinoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cdkn2a-loss","display_name":"CDKN2A loss","score":0.781000018119812},{"id":"https://openalex.org/keywords/p16ink4a","display_name":"p16INK4a","score":0.8650000095367432},{"id":"https://openalex.org/keywords/retinoblastoma-protein","display_name":"retinoblastoma protein","score":0.9259999990463257},{"id":"https://openalex.org/keywords/pi3k-mtor-pathway","display_name":"PI3K/mTOR pathway","score":0.9380000233650208},{"id":"https://openalex.org/keywords/chemotherapy-refractory-disease","display_name":"chemotherapy-refractory disease","score":0.6729999780654907},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.847000002861023},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.5920000076293945},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8623325228691101},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.8408787250518799},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5644532442092896},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5325020551681519},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.5067053437232971},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.4989590644836426},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46818649768829346},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.44550976157188416},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37053319811820984},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3626116216182709},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.1240101158618927},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.09482735395431519},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.07399579882621765},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.tps4150","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4150","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4150","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3083105748","https://openalex.org/W3037437652","https://openalex.org/W2891122889","https://openalex.org/W2532665036","https://openalex.org/W2026890779","https://openalex.org/W2739622482","https://openalex.org/W2949807514","https://openalex.org/W2406260445","https://openalex.org/W4387661717","https://openalex.org/W2154108823"],"abstract_inverted_index":{"TPS4150":[0],"Background:":[1],"mPAC":[2,19,96,140],"has":[3],"a":[4,8,124,194,231,246,338],"poor":[5],"prognosis,":[6],"with":[7,119,141,207,234,337],"5-year":[9],"survival":[10,284],"rate":[11,300],"of":[12,23,35,60,74,87,104,107,157,174,205,230,276,310,328,341],"2.3%.":[13],"CDK4/6":[14,43,61,89,110],"is":[15,123,265,269,281],"often":[16],"deregulated":[17],"in":[18,32,68,95,117,185,193,214,334],"due":[20,70],"to":[21,54,71,197],"loss":[22,34],"CDKN2A":[24],"via":[25],"homozygous":[26],"deletion":[27],"or":[28,177,180],"epigenetic":[29],"silencing,":[30],"resulting":[31],"the":[33,36,45,79,88,102,105,186,199,215,223,277,311,315],"p16INK4a":[37],"protein":[38,47],"that":[39,85],"naturally":[40],"inhibits":[41],"CDK4/6.":[42],"inactivates":[44],"retinoblastoma":[46],"(RB),":[48],"allowing":[49],"E2F":[50],"family":[51],"transcription":[52],"factors":[53],"promote":[55],"cell":[56],"cycle":[57,233],"progression.":[58,272],"Inhibitors":[59],"have":[62,83,137],"been":[63],"ineffective":[64],"as":[65],"single":[66],"agents":[67],"part":[69],"Ras-mediated":[72],"activation":[73],"alternate":[75],"signaling":[76],"pathways":[77,92],"including":[78],"PI3K-mTOR":[80],"pathway.":[81],"We":[82,99],"shown":[84],"co-inhibition":[86],"and":[90,112,149,162,165,210,267,304,320,326],"mTOR":[91,115,178],"suppresses":[93],"growth":[94],"patient-derived":[97],"xenografts.":[98],"are":[100,132,172,291],"investigating":[101],"activity":[103],"combination":[106],"ribociclib":[108,206,221],"(a":[109],"inhibitor)":[111,116],"everolimus":[113,235],"(an":[114],"pts":[118,131],"mPAC.":[120],"Methods:":[121],"This":[122],"phase":[125,187,201,216,241,278],"I/II,":[126],"single-arm,":[127],"open-label":[128],"study.":[129],"Eligible":[130],"\u2265":[133],"18":[134],"years":[135],"old,":[136],"histologically":[138],"confirmed":[139],"progression":[142,282],"on":[143,314],"at":[144,222,286],"least":[145],"1":[146,150],"prior":[147,175],"5-FU-":[148],"gemcitabine-based":[151],"regimen,":[152],"an":[153],"ECOG":[154],"performance":[155],"status":[156],"0-1,":[158],"normal":[159],"bone":[160],"marrow":[161],"hepato-renal":[163],"function,":[164],"no":[166,270],"concurrent":[167],"anticancer":[168],"therapy.":[169],"Exclusion":[170],"criteria":[171],"use":[173,245],"CDK":[176],"inhibitors":[179],"known":[181],"CNS":[182],"metastases.":[183],"Pts":[184,213],"I":[188],"portion":[189,218,243,280],"will":[190,219,244,252,261],"be":[191,253],"enrolled":[192],"3+3":[195],"design":[196],"find":[198],"recommended":[200],"II":[202,217,242,279],"dose":[203,208],"(RP2D)":[204],"escalation":[209],"de-escalation":[211],"levels.":[212],"receive":[220],"RP2D":[224],"daily":[225,238],"for":[226],"21":[227],"days":[228],"out":[229],"28":[232],"2.5":[236],"mg":[237],"continuously.":[239],"The":[240,273],"Simon\u2019s":[247],"Minimax":[248],"2-stage":[249],"design.":[250],"Disease":[251],"assessed":[254],"by":[255,301],"imaging":[256],"every":[257],"8":[258,287],"weeks.":[259,288],"Treatment":[260],"continue":[262],"if":[263],"it":[264],"tolerated":[266],"there":[268],"disease":[271],"primary":[274],"endpoint":[275],"free":[283],"(PFS)":[285],"Secondary":[289],"endpoints":[290],"median":[292,294],"PFS,":[293],"overall":[295,298],"survival,":[296],"best":[297],"response":[299],"RECIST":[302],"1.1,":[303],"safety.":[305],"Correlative":[306],"studies":[307],"include":[308],"assessment":[309],"pharmacodynamic":[312],"effects":[313],"RB":[316],"pathway":[317],"using":[318],"pre-":[319],"on-treatment":[321],"tumor":[322,324,330],"biopsies,":[323],"sequencing,":[325],"analysis":[327],"circulating":[329],"DNA.":[331],"Enrollment":[332],"began":[333],"Q2":[335],"2017":[336],"goal":[339],"accrual":[340],"44":[342],"pts.":[343],"Clinical":[344],"trial":[345],"information:":[346],"NCT02985125.":[347]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-09-27T00:00:00"}